A new patent-infringement complaint landed on the District of Delaware's docket this week, and the question worth answering up front is the one the docket actually settles: who is suing whom, where, and over what. On June 18, 2026, Genesis Growth Tech LLC filed suit against EMOTIV, Inc. — the maker of consumer electroencephalography (EEG) headsets and brain-computer-interface (BCI) software — in the U.S. District Court for the District of Delaware. The case carries docket number 1:26-cv-00715, the cause is coded "35:271 Patent Infringement" with a nature-of-suit of 830 (Patent), and the plaintiff has demanded a jury. As of the docket's current state, the matter is shown as assigned to an unassigned judge, the standard posture for a freshly filed Delaware case before reassignment.

Plaintiff's counsel of record is Brian E. Lutness of Silverman, McDonald & Friedman, per the docket. Everything that follows is drawn from the docket metadata and from the portion of the complaint available through the public RECAP mirror; this is a filing, not an adjudication, and nothing here reflects any finding by the court.

The patent-in-suit and the accused products

The complaint was entered as Docket Entry 1 with several attachments — a 61-page Exhibit 1, a 25-page Exhibit 2, and a civil cover sheet. The body of the complaint (Exhibit 1) is not yet available as text on the public mirror, so its full allegations, including any recitation of asserted claims beyond what the chart shows, are not reproduced here. What is available is Exhibit 2, an infringement claim chart, and it is specific enough to identify both the patent-in-suit and the accused technology.

The claim chart maps a single patent: U.S. Patent No. 11,709,548 B2, titled "Systems, methods, devices and apparatuses for detecting facial expression." According to the patent record, the '548 patent issued on July 25, 2023 and lists MindMaze Group SA as the original assignee; its classifications sit in the facial-expression and EMG-signal art (CPC G06V 40/174 and G06F 3/015, among others). The chart walks the limitations of claim 1 — an "avatar rendering system for rendering a facial expression of a user" — element by element against EMOTIV's products.

The accused products named in the chart are EMOTIV's EPOC X headset and the EmotivBCI software platform. The chart leans on EMOTIV's own published materials to establish the product's characteristics, quoting from EMOTIV's marketing and documentation pages.

As highlighted below, EMOTIV’s own materials disclose EPOC X as a 14-channel wireless EEG headset for neuroscience/BCI use, and EmotivBCI as a platform supporting mental commands, performance metrics, facial expressions, and motion sensors. The EmotiveBCI can be used to animate an avatar of a user with the help of EEG Headset.— Complaint, Exhibit 2 (claim chart), Genesis Growth Tech LLC v. EMOTIV, Inc., 1:26-cv-00715 (D. Del.)

From there, the chart maps the remaining limitations of claim 1 to EMOTIV's disclosed functionality: an apparatus to acquire signals (the chart points to the EPOC headset's sensors), a software ecosystem (it references EMOTIV's Cortex API/SDK), processing of headset-acquired facial-muscle signals, classification of a facial expression — the chart cites EMOTIV's documented detections such as blink, wink, raised eyebrows, furrowed brows, smile, and clenched teeth — and blending and rendering a classified facial expression onto an avatar. In other words, the asserted theory tracks claim 1's recited pipeline from EEG/EMG capture through expression classification to avatar rendering, and reads it onto the EPOC X plus EmotivBCI.

What the docket does and does not establish

It is worth being precise about the limits of a filing-stage record. The claim chart is the plaintiff's contention, not a court's construction of the claims and not a finding that the EPOC X infringes anything. EMOTIV has not yet appeared on the docket or answered, and the chart's reliance on EMOTIV's marketing language is exactly that — the plaintiff's reading of the defendant's public materials, which the defendant will have the opportunity to contest. Whether claim 1's limitations are met, how the claim terms are ultimately construed, and whether the EPOC X and EmotivBCI perform the recited "blend" and "render" steps as claimed are all questions for the litigation, not the docket.

Two further docket-level facts frame the case. First, the patent-in-suit originated with MindMaze Group SA per the public patent record; the plaintiff here, Genesis Growth Tech LLC, is the entity asserting it, and the docket does not on its face explain the chain of title — that detail, if pleaded, would live in the complaint body that is not yet on the mirror. Second, the venue is Delaware, the default forum for patent suits against Delaware-incorporated defendants and a docket that processes a heavy share of the nation's patent litigation; the case has not yet been assigned to a district judge.

The technology context, briefly

EMOTIV builds consumer-grade EEG headsets — the EPOC line among them — marketed for neuroscience research, brain-computer-interface development, and applications that translate brain and facial-muscle signals into commands and metrics. The '548 patent sits squarely in the facial-expression-detection corner of that space: per its title and classification, it is directed at detecting facial expressions from EMG signals and using them to render an expression, and the claim chart's theory is that EMOTIV's expression-detection and avatar-animation features practice that method. For an IP-strategy reader, the cleanest way to track this matter going forward is the pairing the docket already sets up: one asserted patent, the '548, against one named product family, the EPOC X headset and the EmotivBCI platform. The substance of the dispute — claim construction, the validity of the '548, and whether the accused functionality meets the limitations — will be written into the docket from here.

This article reports the filing only. The primary source is the court docket; the patent-in-suit is linked to its canonical record. We will follow the docket as EMOTIV responds and as the case is assigned and construed.